At around 8 o'clock today, the 2026 national basic medical insurance drug catalogue negotiations and commercial insurance innovative drug catalogue price negotiations officially began. The reporter observed at the scene that representatives from nearly 20 companies, including China Resources Shuanghe, MSD, Yuanda Pharmaceuticals, First Drug Holdings, China and the US, East China, Chia Tai Tianqing, Abbvie, and Novartis, entered the venue one after another. There are still quite a few oncology drugs being negotiated today.

At around 8 o'clock today, the 2026 national basic medical insurance drug catalogue negotiations and commercial insurance innovative drug catalogue price negotiations officially began. The reporter observed at the scene that representatives from nearly 20 companies, including China Resources Shuanghe, MSD, Yuanda Pharmaceuticals, First Drug Holdings, China and the US, East China, Chia Tai Tianqing, Abbvie, and Novartis, entered the venue one after another. There are still quite a few oncology drugs being negotiated today.